Progesterone
Product Images NDC 53002-2760

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 53002-2760). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

A step-plot chart showing the probability of hyperplasia over time (in months) on medication for three groups: Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only. The x-axis represents time up to 36 months, and the y-axis represents the probability of hyperplasia. The chart includes the sample size at each time point.*

FDA Label Image

Label Image (Lbl530022760)

Progesterone 200 mg capsules packaging label from RPK Pharmaceuticals, Inc. Displays product name, strength, dosage form, quantity (30 capsules), dosing instructions (take 1 capsule twice a day or as directed), and various barcodes and billing codes. Includes blank fields for clinic name, patient information, and prescription details.*

FDA Label Image

Chemical Structure (Prog Structure)

Chemical structure diagram of progesterone showing its steroid backbone with various methyl groups and ketone functional groups, as typically depicted in pharmaceutical product labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.